Information Library

Results for: Product Development & Commercialization - Phase II/III

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title
  • Quintiles Names New Global Head of Clinical & Data Operations

    Press Release — October 6, 2011 – Quintiles announced that Steven Skolsky has been appointed Global Head of its Clinical & Data Operations (CDO) unit.

  • A Focus on CNS

    Brochure — July 1, 2011
    Quintiles is your ally for broad and deep CNS expertise in every aspect of the drug development process.

  • The Molecular Biomarker Revolution in Non-Small Cell Lung Cancer

    White Paper — June 23, 2011
    In this new white paper Quintiles’ experts Christopher Ung, Jason Hill, Carrie Lee and Harish Dave review some of the most promising molecular pathways and targeted approaches for NSCLC, the critical role of diagnostics, and strategies to detect and address the emergence of resistance.

  • Biomarkers in Alzheimers Disease

    Presentation — March 17, 2011
    The Quintiles Innovation Unit shares their knowledge on the use of biomarkers in compound development in clinical trials.

  • Exclusive Report From Scientific American

    Hear from the Experts — November 9, 2010
    In-depth insights on every angle of the changing health landscape - brought to you by Quintiles Get the report today.

  • Healthcare's Future Tools

    Hear from the Experts — November 8, 2010
    Beyond Genomics. The knowledge gained in mapping the genome is producing more tools and new ways of understanding how the human body works. See what's in store in this exclusive report.

  • Oncology Drug Development and Value-Based Medicine

    White Paper — November 5, 2010
    This report demonstrates the need to converge clinical and commercial imperatives earlier within the drug development process to meet a future demand for value-based medical practices.

  • Pharmacobiomics and Infectious Disease: Progress and Opportunities

    White Paper — November 2, 2010
    Pharmacobiomics and Infectious Disease: Progress Opportunities. After decades of work mapping the human genome, we are beginning to reap real benefits.

  • From Biomarkers to Diagnostics - The Road to Success

    White Paper — October 18, 2010
    In the second installment of a two-part series, Eric Groves, Jason Hill and Christopher Ung walk through the challenges associated with drug-diagnostic co-development, addressing potential pitfalls and areas of opportunity.

  • Advancing Clinical Research in Alzheimer's Disease

    White Paper — October 18, 2010
    This report from Quintiles’ own Alzheimer’s experts gives you an inside look at the news from ICAD 2010.

Page 1 of 4 (38 results)

Subscribe to Email Based on Your Interests

Set preferences